IN.PACT™ Quality of Life Post-Reimbursement Study

Active, not recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

February 17, 2021

Primary Completion Date

November 8, 2023

Study Completion Date

December 31, 2024

Conditions
Obstructive DiseaseAtherosclerosis of Femoral ArteryAtherosclerosis of Popliteal Artery
Interventions
COMBINATION_PRODUCT

IN.PACT™ Admiral™ Drug Coated Balloon (DCB)

For percutaneous transluminal angioplasty (PTA) in subjects with obstructive disease of the peripheral arteries.

Trial Locations (9)

63000

Centre Hospitalier Clermont-Ferrand-Gabriel-Montpied, Clermont-Ferrand

75674

Groupe hospitalier Paris Saint-Joseph, Paris

Unknown

Hopitaux Universitaires Paris lle-France Ouest- Hopital Ambroise- Pare, Boulogne

CHRU Brest Cavale Blanche, Brest

Hopital Europeen Georges-Pompidou, Paris

CHU de Rennes, Rennes

Clinique Rhena, Strasbourg

Hopitaux Universitaires de Strasbourg - Nouvel Hopital Civil, Strasbourg

Clinique Pasteur, Toulouse

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic

INDUSTRY

NCT04597307 - IN.PACT™ Quality of Life Post-Reimbursement Study | Biotech Hunter | Biotech Hunter